Skip to main content
PB Fintech Limited logo

PB Fintech Limited — Investor Relations & Filings

Ticker · POLICYBZR ISIN · INE417T01026 LEI · 98450083AC6B01HF1F87 BSE.NS Financial and insurance activities
Open in API
Filings indexed 461 across all filing types
Latest filing 2025-11-26 Regulatory Filings
Country IN India
Listing BSE.NS POLICYBZR

About PB Fintech Limited

https://www.pbfintech.in/

PB Fintech Limited operates as a technology platform providing integrated online marketing and consulting services for financial products. The company functions through its flagship brands, Policybazaar and Paisabazaar. Policybazaar serves as a digital marketplace for insurance, allowing users to compare and purchase products such as life, health, motor, and travel insurance from a wide range of providers. Paisabazaar operates as a digital platform for lending products, offering consumers access to personal loans, credit cards, and credit score management tools. The company leverages data analytics and proprietary technology to enhance transparency and efficiency in the financial ecosystem, facilitating informed decision-making for consumers while providing partners with targeted distribution channels and risk assessment capabilities.

Recent filings

Filing Released Lang Actions
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice dated November 26, 2025, addressed to stock exchanges, informing about the schedule of an upcoming analyst meet (Morgan Stanley Virtual New Age India Tech Seminar) on December 8-9, 2025. It explicitly states it is an intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which governs disclosure of material events and information. The document does not contain any financial data, results, or detailed report content. It is a notification of an event (investor conference) rather than a report or transcript. The length is only 1791 characters, well under the threshold for a full report. Therefore, this is best classified as a Regulatory Filing (RNS), which covers general regulatory announcements and disclosures that do not fit other categories.
2025-11-26 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a formal communication addressed to stock exchanges (NSE and BSE) regarding the schedule of an analyst meeting. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) – Regulations, 2015, which pertains to disclosure of material events and information. The content is an intimation about the date, mode, and location of a management meeting with investors, explicitly stating that no unpublished price sensitive information will be shared. The document is short (1791 characters) and serves as a notification of an upcoming investor event rather than a detailed report or transcript. It does not contain financial data, earnings, or detailed presentations. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements and disclosures that do not fit other specific categories.
2025-11-26 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a formal notification addressed to stock exchanges regarding the schedule of an upcoming analyst meet. It references compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and provides details about the date, event, mode, and time of the investor conference. The document explicitly states that no unpublished price sensitive information will be shared and is primarily an announcement of a scheduled investor event. It does not contain any financial data, report content, or detailed presentation materials. Given the nature of the document as an announcement of an investor meeting schedule, it fits best under the category of Investor Presentation (IP), which includes detailed presentations for investors focusing on financials, strategy, and market position. However, since this document only announces the schedule and does not contain the presentation itself, it is more appropriate to classify it as a Regulatory Filing (RNS), which serves as a fallback for miscellaneous regulatory announcements and compliance documents that do not fit other categories. The document length is short (1774 characters), and it is an intimation rather than a report or transcript. Therefore, the best classification is Regulatory Filings (RNS).
2025-11-25 English
ESOP/ESOS/ESPS
Share Issue/Capital Change Classification · 95% confidence The document is a corrigendum disclosure related to the allotment of equity shares upon exercise of employee stock options under the company's ESOP 2021 plan. It references compliance with SEBI Listing Obligations and Disclosure Requirements Regulations, 2015, and SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021. The document details the number of shares allotted, the increase in paid-up capital, and confirms the shares rank pari passu with existing shares. It includes an annexure with detailed disclosure pursuant to SEBI regulations. The content is an official announcement of a share allotment event related to employee stock options, which is a capital change event. It is not a full financial report, audit, or earnings release, nor is it a meeting material or voting result. The document is not a report publication announcement as it contains substantive disclosure details. Therefore, the most appropriate classification is Share Issue/Capital Change (SHA).
2025-11-21 English
ESOP/ESOS/ESPS
Share Issue/Capital Change Classification · 95% confidence The document is an official communication to stock exchanges regarding the allotment of equity shares following the exercise of vested employee stock options under the company's ESOP 2021 plan. It includes detailed disclosure pursuant to SEBI regulations about the share allotment, share capital changes, and compliance with listing requirements. The document is a regulatory announcement about a capital change (allotment of shares) rather than a financial report or earnings release. It does not contain financial statements or management discussion but focuses on share issuance details. Therefore, it fits the category of Share Issue/Capital Change (SHA). The document length is 4737 characters, which is sufficient for a detailed announcement but not a full report. Confidence is high due to clear regulatory references and detailed share issuance data.
2025-11-07 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 100% confidence The document is a detailed transcript of an earnings call held on October 29, 2025, for PB Fintech Limited's Q2 FY 2025-26 results. It includes management commentary on financial performance, revenue growth, margins, business segments, and responses to analyst questions. The text explicitly states it is a transcript of the earnings call and contains detailed discussion of quarterly financial results and business outlook. This matches the definition of a Call Transcript (CT). The document length is substantial (15,000 characters), and it contains the full text of the call, not just an announcement or summary. Therefore, the correct classification is Call Transcript (CT).
2025-11-04 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.